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Present investigation revealed that 3T3-Ll cells contained two protein kinase C (PKC) subspecies, i.e. CL- and jI-PKC. These cells treated by 
staurosporine. a specitic inhibitor of PKC, differentiated to adipocytes more remarkably than those without its treatment. Their u- and &PKC 
activity decreased to 49% and 18% ofthc staurosporine-untreated cells respectively, and GPDH activity. a marker enzyme of adipocytes, increused 
to 143%. Thus, both OL- and &PKC seemed to bc associated with the adipose conversion in 3T3-Ll cells. 
Differentiation; 3T3-Ll cell: Protein kinase C subspecies; Staurosporine 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Protein kinase C (PKC) plays an important role in 
various cellular functions including proliferation and 
differentiation, and consists of several subspecies [l-6]. 
They have been shown to exist in many cells and tissues 
at va.rious combinations and to be associated with dif- 
ferentiation in a certain type of cells [3,4]. 3T3-Ll cells 
can be induced to differentiate to adipocytes by various 
agents, i.e. 3-isobutyl-1-methylxanthine (ISMX), dexa- 
methasone. insulin and dihydroxyvitamin DI, [7-g]. 
However. in 3T3-Ll cells the subspecies of PKC had not 
been identified and their role in the differentiation has 
not been investigated. 
In the present investigation we report the identifica- 
tion of PKC subspecies in 3T3-L I cells, using antibodies 
against a subspecies-specific sequence. Furthermore, we 
studied the involvement of PKC subspecies to adipose 
conversion of 3T3-Ll cells both morphologically and 
biochemically through PKC inhibition by treatment 
with staurosporine. which is a specific inhibitor of PKC 
[lo] and induces cellular proliferation [l l] and differen- 
tiation [12]. 
Abbrevintiom: protein kinase C(PKC), Ca”/phospholipid-dependent 
protein kinase: IBMX. 3-isobutyl- I-methylxanthinc; GPDH, glyccrol- 
3-phosphate dchydrogenase; PMSF, phenylmethylsulfonylfluoride: 
PS. phosphatidylserinc: DG. diacylglycerol; DMEM. Dulbccco’s mo- 
dified Eagle’s medium: FCS, fetal calf serum; EDTA, ethylenediilmi- 
netetra:>cctic a id: EGTA. ethyleneglycol-bis-(aminoethylether)tetra- 
acetic acid; MBpLiJ. synthetic mycliu basic protein. 
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7-chomc. Chuo-ku. Kobe 650. Japan. Fax: (81) (78) 382-2080. 
2. I . ClW??iCff Is 
Staurosporine was donated by Kyowa Hakko Co.. Tokyo. Japan, 
3-Isobutyl-I-metbylxanthine (IBMX), dexamethasone. leupeptin and 
phenylmethylsulfonylfluoride (PMSF) were purchased from Sigma 
Chemical Co. (St. Louis. MO). Phosphatidylserine (PS) and diacylgly- 
cerol (DG) were from Serdary Research Laboratories, London, Onta- 
rio. Canada. DuIbecco’s modified Eagle’s medium (DMEM) was from 
Nissui Co.. Tokyo, Japan. Fetal calf serum (FCS) was from Bio. 
products, (Walkersville. MD). Penicillin-streptomycin and L&I- 
taminc were from Flow Laboratories, Irvine, Scotland. [y-“P]ATP 
was from Du Pont/NEN Research Products. (Boston, MA). 
3T3-Ll cells were a generous gift of Japanese Cancer Research 
Resources Bank (JCRBI-Cell, Tokyo, Japan. They were routinely 
nrown in DMEM supplemented with 10% FCS. 2 mM L-glutamine, 
penicillin (50 U/ml) and streptomycin (50,ug/ml). Cultures were main- 
tained at 37°C in a 95% sir/5% COz atmosphere. 
The differentiation to mature adipocytes was induced by the addi- 
tion of 0.5 mM IBMX and 0.25 flM dcxamcthasone to confluent 
3Tf-LI preadipocytes. In 48 hours. medium was substituted with 
above-mentioned Fresh medium without IBMX and dexamethasonc. 
Adipose conversion was determined morphologically by the appear- 
ancc of fat droplets in the cytoplasm and was quantified by the 
measurement of glycerol-3-phosphate dehydrogenase (GPDH), a 
marker enzyme of adipocytes [9.13]. 
GPDH assay was carried out by the method of Kozak and Jensen 
[I41 with our modifications described elsewhere [9]. One unit of cn. 
zyme activity was defined as the oxidation of I .O pmol of NADH per 
min per mgprotein. Protein concentration wasdetermined by Lowry’s 
method [I 5). 
2.5. Separcrriorl arrd assay of prorein kimue C 
All procedures were performed at O-QYZ. 3T3-Ll cells (I .O x IO’) 
wcrc suspended in IO ml of 20 mM Tris-HCI (pH 7.5) containing 0.25 
M sucrose, I .O mM EDTA, 3.0 mM EGTA, 1 .O mM PMSF and 0.4 
mM leupcptin. The cells were lysed by sonication. and centrifuged for 
60 rain at 100 000 )r: g. The supernatant was applied to a DE-52 column 
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(Whatman) equilibrated beforehand with buffer A consisting of 0.5 
mM EDTA. 0.5 mM EGTA and I 0 mM 2-mercaptoethanol in 20 mM 
Tris-HC! (pH 7.5). After washing the column with 40 ml buffer ~, 
PKC was eluted by 10 ml buffer A containing 0.5 M NaCI. The 
enzyme fraction was applied to a hydroxyapatite column (Koken Co., 
Tokyo, Japan) connected to an FPLC system and equilibrated before- 
hand with buffer B consisting of 0.5 mM EDTA, 0.5 mM EGTA. 10 
mM 2-mercaptoethanol and 10% (v/v) glycerol in 20 mM potassium 
phosphate (pH 7.5). PKC subspecies were eluted by increasing the 
concentration ofpotassium phosphate linearly from 20 to 200 mM at 
a flow rate of 0.4 ml/min. Fractions of 1.0 ml were collected. PKC 
aclivity in cytosolic fractions was determined by the incorporation of 
.Up into oligopeptide MBF~I4 (QKRPSQRSKYL) from [7-3-~P]ATP 
for 15 rain at 30°C. and indicated as nmol phosphate incorporation 
per rain per mg cytosolic protein. A reaction mixture of 50/.tl for the 
assay of PKC contained tissue extracts (6/.tl) along with 20 mM 
Tris-HCl (pH 7.5). 5 mM magnesium acetate. 10/JM of [7-~ZP]ATP 
(20-30 epm/nmol), 8 pg/ml PS. 0.8/a'g/ml DG. 65/.tM CaCI.. and 25 
/.zM MBP4-,4. 
2.6. hnmunoblotting 
The polyclonal antibodies were prepared against the s quence-spe- 
cific oligopeptides to ~-..ft. and 7-PKC as well as the kinase domain 
specific oligopeptides [16]. 
3. RESULTS 
3.1. Isolation of  PKC subspecies #1 3T3-LI cells 
The soluble cytoplasmic fraction of pre-differentiated 
3T3-LI cells was subjected to hydroxyapatite column 
chromatography using FPLC system as described 
above (Fig. 1). Two major peaks of the activity were 
detected at the fraction number 36-42 (peak 1) and 
52-57 (peak 2). Furthermore, the PKC subspecies of 
peak 1 and 2 were determined to be fl- and ~-PKC, 
respectively, by immunoblotting (Fig. 2). 7-PKC was 
not found in 3T3-L! cells and the other subspecies were 
not studied in the present investigation. 
20 
10 
25 35  45 55 65 75 
Fract ion  number  
c 
u~ 
.2 
-200  
O 
o 
Cu 
zoo 
O 
Fig. 1. Specific activity of protein kinase C of pre-differentiated 3T3- 
LI cells. DE-52-purified PKC was fractionated on a hydroxyapatite 
column chromatography and assayed as described in section2.5, PKC 
activity was assayed in the presence of 8 ~,g/ml PS. 0.8 pg/ml DG and 
65 pM CaCI, (e). while tilat for the control in the presence of 5 mM 
EG'I'A (' ,). 
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Fig. 2. PKC subspecies of 3T3-LI cells by immunoblotting. Panel (A) 
and (B) are an immunoblotting bypolyclonal antibody against 0~- and 
fl-PKC, respectively. Fractions of peak 1 and 2 shown in Fig. I were 
dialysed and lyophilysed. 100 ng of this lyophilysate from peak I and 
2 was applied to htne 1 and 2, respectively. Lane ~. fl and 7 was for 
100 ng of ~-. ,8- and 7-PKC from rat brain, respectively. 
3.2. Staurosporine-untreated 3 T3-L 1 cells 
During differentiation of stuarosporine-untreated 
3T3-LI cells, the activity of cytosolic ~-PKC decreased 
to 85 and 50% ofpre-differentiation level of 102.3 nmol/ 
min/mg protein on the 4th and 8th culture day after the 
induction of differentiation respectively (Fig. 3). On the 
other hand, the fl-PKC activity did not change till the 
8th culture day. It was 48 and 41% of pre-differentiation 
level of 28.3 nmol/min/mg protein on the 4th and the 8th 
culture day. Morphologically, however, 3T3-LI cells on 
the 4th culture day after the induction of differentiation 
had small lipid-like droplets in the cytoplasm and be- 
came slightly rounded in shape compared with pre-dif- 
ferentiated cells which looked like fibroblasts (Fig. 4A). 
On the 8th culture day, lipid droplets in the cytoplasm 
became larger and the cells looked more rounded in 
shape, and, moreover, such cells increased in number 
(Fig. 4B). The activity of GPDH increased to 155 and 
303% of the level of pre-differentiated cells of 41.1 U on 
the 4th and the 8th culture day, respectively (Fig. 3). 
3.3. Staurosporine-treated 3T3-L1 ceils' 
The activity of cytosolic 0~- and fl-PKC of 3T3-LI 
cells treated with stauresporine decreased to 61 and 
28% of the value of pre-differentiated cells, i.e. 102.3 
and 28.3 nmol/min/mg protein, on the 4th culture day 
after the induction of differentiation. Furthermore, they 
decreased to 25 and 8% on the 8th culture day (Fig. 3). 
Morphologically, staurosporine-trcated 3T3-L1 cells on 
the 4th culture day after the induction of differentiation 
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Fig. 3. Relative activity ofcytosolic 0~- (A) and fl.PKC (B) and GPDH 
(C) during differentiation. Activity is shown as % of that of pre- 
differentiated 3T3-LI cells. Each column is indicated as follows: [3, for 
pre-differentiated cells; ~, for staurosporine-untreated ceils; ~, for 
staurosporine-treated cells. 
gree by different agents used [22]. In the present study, 
fl-PKC of 3T3-LI cells was shown to be inhibited more 
remarkably than ¢z-PKC by staurosporine. Thus, this 
rate of suppression of PKC subspecies in the presence 
offl-PKC might be related to the induction of differen- 
tiation in these cells. 
The inhibition of phosphorylation of a certain 
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had larger lipid droplets in the cytoplasm and became 
more rounded in shape than staurosporine-untreated 
cells. On the 8th culture day, lipid droplets became 
much larger and the cells much more rounded, but no 
distinct difference was observed morphologically be- 
tween staurosporine-treated an  untreated cells (Fig. 
4C). However, the GPDH activity increased to 204 and 
433% of the pre-differentiated cells, i.e. 41.1 U, on the 
4th and 8th culture day, respectively (Fig. 3). 
4. DISCUSSION 
This is the first report o show the presence ofc~- and 
fl-PKC in 3T3-L1 cells and the decrease of these PKC 
subspecies might be associated with the potentiation of 
differentiation of the 3T3-L1 cells to adipocytes. Stau- 
rosporine, though first reported to be the most potent 
inhibitor of PKC [7], was also found to inhibit various 
protein kinases at a certain range of concentrations [17] 
and induce cell differentiation i some types of cells 
[18-20]. The concentration of staurosporine used in the 
present study seems to be suitable for the potentiation 
of PKC to differentiate he 3T3-LI cells [7,21]. 
In our preliminary study I0-1000 nM of 12-O-tetra- 
decanoyl-phorbol-13-acetate (TPA), an activator of 
PKC, did not enhance adipose conversion of 3T3-L1 
cells. The present study suggested that inhibition rather 
than activation of PKC appears to be associated with 
differentiation of 3T3-L1 cells. There are also some 
reports that other PKC inhibitors enhanced ifferentia- 
tion in neuroblastoma cells [18,19] and HL-60 cells [20]. 
Subspecies of PKC are suppressed to a different de- 
Fig. 4. Morphological change during differentiation f 3T3-L1 cells. 
Pre-differentiated cells, staurosporine-untreated cells and treated cells 
on the 8th culture day after induction of differentiation are shown in 
panel (A), (B) and (C) at a magnification of 312, respectively. 
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protein in the cell might be a trigger of differentiation 
through various signaling processes. However, it is not 
determined that the decrease of PKC activity is a cause 
or a result of differentiation. In order to clarify this 
point the investigation on PKC activity in the earlier 
stage of differentiation is necessary. 
Meanwhile, since cyclic-AMP was reported to be in- 
volved in the cell differentiation i  3T3-LI cells [8], it 
might be suggested that the factor influencing differen- 
tiation of3T3-Ll cells is the ratio between PKC subspe- 
cies, between cyclic-AMP dependent protein kinase and 
PKC, or between other protein kinases and PKC. 
In summary, cx- and/3-PKC are found in 3T3-L1 cells 
and the decrease of these PKC subspecies might be 
associated with the potentiation of differentiation of the 
3T3-LI cells to adipocytes. 
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